Dr. Reddy's Laboratories

Indian multinational pharmaceutical company

Dr. Reddy's Laboratories ▸ Facts ▸ Comments ▸ News ▸ Videos

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company located in Hyderabad, Telangana, India. The company was founded by Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products.

0 shares	Share Tweet Save Post Send



42% patients experience freedom from oxygen dependence: DRDO scientist on 2-DG clinical trials Institute of Nuclear Medicine and Allied Sciences-DRDO scientist Dr Sudhir Chandna on drug 2-deoxy-D-glucose (2-DG) while speaking to ANI informed about the observations of the medicine's clinical.. Credit: ANI Duration: 01:59Published 4 days ago

Sputnik V is stored at -18C: Dr Reddy's Lab Global Logistics' Head Sputnik V is a minus 18-degrees Celsius storage vaccine, informed Ravi Mathur, Global Logistics' Head, Dr Reddy's Laboratories after the Russian vaccines arrived in India on May 01."Sputnik V is a.. Credit: ANI Duration: 01:43Published 2 weeks ago

Sputnik V will be available in few weeks after statutory clearances: Dr Reddy's Lab CEO The Sputnik V vaccine will be available in a few weeks after statutory clearances, informed Deepak Sapra, CEO of Dr Reddy's Laboratories after the Russian vaccines arrived in India on May 01. "Today,.. Credit: ANI Duration: 01:02Published 2 weeks ago

150,000 doses of Sputnik V have arrived in India on 1st May \| Oneindia News Sputnik V is the Russian made covid vaccine with an efficacy rate above 90%. 150,000 doses of Sputnik have arrived at Hyderabad in India on Saturday. The vaccines will be handed over to Dr Reddy's.. Credit: Oneindia Duration: 01:01Published 2 weeks ago

You Might Like

Potential cancer drug repurposed for Covid-19 by DRDO, Dr Reddy's gets DCGI nod for emergency use A potential cancer drug repurposed for Covid-19 treatment -- 2-deoxy-D-glucose (2-DG) – has received the Drugs Controller General of India (DCGI) nod for emergency use as adjunct therapy for.. IndiaTimes - Published 5 days ago
Sputnik V cleared for launch in India: Five things you need to know about Russian Covid-19 vaccine Dr Reddy's Laboratories said on Tuesday it has received permission from the Drug Controller General of India (DCGI) to import the Sputnik vaccine into India for restricted use in emergency situations... IndiaTimes - Published on April 13, 2021
Expert panel seeks additional data from Dr Reddy's Laboratories on Russian Covid vaccine Sputnik V IndiaTimes - Published on April 1, 2021

Dr Reddy's initiates process for emergency use authorisation of Sputnik V Dr Reddy's Laboratories said on Friday it has initiated the process with the Drugs Controller General of India (DCGI) for emergency use authorisation of human adenoviral vector-based platform vaccine.. IndiaTimes - Published on February 19, 2021
Sputnik V India rollout in emergency use authorisation mode expected in March The Russian Covid-19 vaccine Sputnik V is expected to be rolled out into the Indian market in March this year in EUA (emergency use authorisation) mode, a top official of Dr Reddy’s Laboratories said.. IndiaTimes - Published on January 29, 2021
All Indian vaccines being developed for storage at 2-8 degree Celsius: DBT secretary Swarup said Dr Reddy's Laboratories has partnered with Russia's Gamaleya Institute and a vaccine is being developed for India targeting storage at 2-8 degrees Celsius. The country's drugs regulator.. IndiaTimes - Published on January 5, 2021

Russia will jointly produce Sputnik V vaccine with India: Envoy Russian envoy in New Delhi Nikolay Kudashev on Monday said Moscow will jointly produce the Sputnik V vaccine for Covid-19 along with India and it will be manufactured by Indian pharma major Dr Reddy's.. IndiaTimes - Published on December 21, 2020
Dr Reddy's, RDIF begin clinical trials for Russia's Sputnik V vaccine in India Dr Reddy's and RDIF had entered into a partnership to conduct clinical trials and rights for distribution of the first 100 million doses in India. DNA - Published on December 1, 2020
India trials of Russian Sputnik-V vaccine may end as early as March: Dr Reddy's The company expects to enrol 100 participants for the mid-stage trial and 1,500 people for the late-stage. DNA - Published on October 28, 2020Also reported by •IndiaTimes
Russian Sputnik V Covid-19 vaccine to be tested on 100 Indian volunteers The Russian Sputnik V vaccine against Covid-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) told Sputnik on.. IndiaTimes - Published on October 23, 2020

Dr Reddy's gets DCGI go-ahead to conduct Phase 2/3 human trials of Sputnik V in India After the Indian drug regulator turned down Dr. Reddy’s Laboratories Ltd’s proposal earlier this month to conduct direct Phase-3 human trials for the Russian Covid-19 vaccine Sputnik V, the company.. IndiaTimes - Published on October 17, 2020
India declines proposal to test Sputnik-V Covid-19 vaccine in large study India's drug regulator has knocked back a proposal from Dr Reddy's Laboratories Ltd to conduct a large study in the country to evaluate Russia's Sputnik-V Covid-19 vaccine and has asked it to first.. IndiaTimes - Published on October 8, 2020
COVID-19 vaccine to be available in India by early 2021: Union Health Minister Harsh Vardhan Meanwhile, Russia's sovereign wealth fund on Wednesday agreed to supply 100 million doses of the world's first COVID-19 vaccine Sputnik-V to Indian drug company Dr Reddy's Laboratories as Moscow speeds.. DNA - Published on September 17, 2020	Russia, Dr Reddy’s tie up for Sputnik V trial Russia’s sovereign wealth fund – Russian Direct Investment Fund (RDIF) — has partnered Hyderabad-based drug maker Dr Reddy’s Laboratories to cooperate on clinical trials and distribution of.. IndiaTimes - Published on September 16, 2020
Russia confirms deal with Dr. Reddy's for COVID-19 vaccine 'Sputnik V' trials in India, to supply 100 million doses Russia's sovereign wealth fund on Wednesday agreed to supply 100 million doses of world's first COVID-19 vaccine Sputnik-V to Indian drug company Dr Reddy's Laboratories as Moscow speeds up plans to.. DNA - Published on September 16, 2020	Russia to sell 100 million doses of Covid-19 vaccine to India Russia's sovereign wealth fund said on Wednesday it will supply India's Dr Reddy's Laboratories with 100 million doses of the Sputnik-V vaccine against Covid-19 once it receives regulatory approval... IndiaTimes - Published on September 16, 2020

Dr. Reddy's Laboratories

Indian multinational pharmaceutical company

Dr. Reddy's Laboratories ▸ Facts ▸ Comments ▸ News ▸ Videos

You Might Like

Potential cancer drug repurposed for Covid-19 by DRDO, Dr Reddy's gets DCGI nod for emergency use

Sputnik V cleared for launch in India: Five things you need to know about Russian Covid-19 vaccine

Expert panel seeks additional data from Dr Reddy's Laboratories on Russian Covid vaccine Sputnik V

Dr Reddy's initiates process for emergency use authorisation of Sputnik V

Sputnik V India rollout in emergency use authorisation mode expected in March

All Indian vaccines being developed for storage at 2-8 degree Celsius: DBT secretary

Russia will jointly produce Sputnik V vaccine with India: Envoy

Dr Reddy's, RDIF begin clinical trials for Russia's Sputnik V vaccine in India

India trials of Russian Sputnik-V vaccine may end as early as March: Dr Reddy's

Russian Sputnik V Covid-19 vaccine to be tested on 100 Indian volunteers

Dr Reddy's gets DCGI go-ahead to conduct Phase 2/3 human trials of Sputnik V in India

India declines proposal to test Sputnik-V Covid-19 vaccine in large study

COVID-19 vaccine to be available in India by early 2021: Union Health Minister Harsh Vardhan

Russia, Dr Reddy’s tie up for Sputnik V trial

Russia confirms deal with Dr. Reddy's for COVID-19 vaccine 'Sputnik V' trials in India, to supply 100 million doses

Russia to sell 100 million doses of Covid-19 vaccine to India